May 02, 2019

Two More Pharmaceutical Companies Will Pay Approximately $125 Million Due to Copay Assistance Foundations

Last Thursday, DOJ announced that Astellas Pharma US Inc.  and Amgen Inc. have agreed to pay a total of $124.75 million to resolve FCA allegations arising from their illegal Medicare copayments for their own products, orchestrated through purportedly independent foundations that were used as mere pass through entities.